STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
PACB PACIFIC BIOSCIENCES OF CALIFORNIA INCO StockScouter® Report
5
StockScouter® Score
PACIFIC BIOSCIENCES OF CALIFORNIA INCO, a small cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is above average. Positive/Neutral
- One or more less experienced analysts has modestly increased quarterly earnings estimates for PACB. Positive/Neutral
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Moving average analysis for PACB suggests weak price movement over the medium term. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
C
D
B